These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment of leukemic relapse following unrelated umbilical cord blood transplantation with interleukin-2: potential for augmenting graft-versus-leukemia and graft-versus-host effects with cytokines. Goldberg SL; Pecora AL; Rosenbluth RJ; Jennis AA; Preti RA Bone Marrow Transplant; 2000 Aug; 26(3):353-5. PubMed ID: 10967580 [TBL] [Abstract][Full Text] [Related]
23. Umbilical cord blood offers another option for leukemia patients. Christensen D J Natl Cancer Inst; 2005 Feb; 97(4):253-4. PubMed ID: 15713957 [No Abstract] [Full Text] [Related]
24. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies. Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401 [TBL] [Abstract][Full Text] [Related]
25. Cord blood transplantation in adults with acute myeloid leukaemia. Arcese W; Buccisano F; Cerretti R; Picardi A; Best Pract Res Clin Haematol; 2010 Jun; 23(2):197-206. PubMed ID: 20837331 [TBL] [Abstract][Full Text] [Related]
26. Unrelated cord blood transplantation in children with severe congenital neutropenia. Yesilipek MA; Tezcan G; Germeshausen M; Kupesiz A; Uygun V; Hazar V Pediatr Transplant; 2009 Sep; 13(6):777-81. PubMed ID: 18992063 [TBL] [Abstract][Full Text] [Related]
27. [Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors]. Hyo R; Taguchi J; Kamijo A; Tanaka M; Hashimoto C; Kanamori H; Motomura S; Maruta A; Ishigatsubo Y Gan To Kagaku Ryoho; 2009 Nov; 36(11):1845-9. PubMed ID: 19920386 [TBL] [Abstract][Full Text] [Related]
28. [Long-term remission in an acute monoblastic leukemia patient with down syndrome after cord blood transplantation]. Kurosawa H; Tsuboi T; Shimaoka H; Okuya M; Nakajima D; Matsunaga T; Hagisawa S; Sato Y; Sugita K; Eguchi M Rinsho Ketsueki; 2005 Apr; 46(4):274-7. PubMed ID: 16444960 [TBL] [Abstract][Full Text] [Related]
29. [Killer cell immunoglobulin receptor plays an important role in cord blood transplantation for leukemia]. Zhang X; Liu KY; Lu DP Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2962-5. PubMed ID: 17288806 [TBL] [Abstract][Full Text] [Related]
30. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Dalle JH; Duval M; Moghrabi A; Wagner E; Vachon MF; Barrette S; Bernstein M; Champagne J; David M; Demers J; Rousseau P; Winikoff R; Champagne MA Bone Marrow Transplant; 2004 Mar; 33(6):605-11. PubMed ID: 14743192 [TBL] [Abstract][Full Text] [Related]
32. A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblings. Papineschi F; Benedetti E; Galimberti S; Caracciolo F; Fazzi R; Petrini M Bone Marrow Transplant; 2004 Mar; 33(6):659-60. PubMed ID: 14755324 [TBL] [Abstract][Full Text] [Related]
33. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Rocha V; Mohty M; Gluckman E; Rio B; ; ; Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S31-4. PubMed ID: 19561411 [TBL] [Abstract][Full Text] [Related]
34. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy. Hwang WY; Goh YT; Tan CH; How GF; Tan HC Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682 [TBL] [Abstract][Full Text] [Related]
35. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen. Kröger N; Zabelina T; Binder T; Ayuk F; Bacher U; Amtsfeld G; Lellek H; Schrum J; Erttmann R; Eiermann T; Zander A Biol Blood Marrow Transplant; 2009 Apr; 15(4):454-62. PubMed ID: 19285633 [TBL] [Abstract][Full Text] [Related]
36. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase. Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121 [TBL] [Abstract][Full Text] [Related]
37. Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma. Toubai T; Hirate D; Shono Y; Ota S; Ibata M; Mashiko S; Sugita J; Shigematsu A; Miura Y; Kato N; Umehara S; Kahata K; Tsutsumi Y; Iwao N; Toyoshima N; Tanaka J; Asaka M; Imamura M Int J Lab Hematol; 2008 Feb; 30(1):75-81. PubMed ID: 18190473 [TBL] [Abstract][Full Text] [Related]
38. Ocular complications in a child with acute graft-versus-host disease following cord blood stem cell transplantation: therapeutic challenges. Uchino M; Ogawa Y; Kawai M; Shimada H; Kameyama K; Okamoto S; Dogru M; Tsubota K Acta Ophthalmol Scand; 2006 Aug; 84(4):545-8. PubMed ID: 16879579 [TBL] [Abstract][Full Text] [Related]